glp-1 and ibs Frontiers GLP-1 Medicines And Gut Bacterial

These werent anecdotal reports

Arch Gerontol Geriatr 46: 181190.

Choose Health is preparing to publish a clinical outcomes report in mid-2026 drawing on data from over 150,000 at-home blood tests

Good sources of soluble fiber include vegetables, fruits, and whole grains

Saxenda (active ingredient: liraglutide) subcutaneous injection Initial FDA Approval: 2014 (liraglutide approved in 2010) Side Effect Update Date: May 28, 2025 Medication Description: For chronic weight management Updated Side Effects/Safety Information: A new warning section on Severe Gastrointestinal Adverse Reactions. An additional warning about the risk of serious kidney injury caused by dehydration due to gastrointestinal adverse effects like diarrhea and vomiting

No concerns here